Description
Mitochondrial-derived peptide studied for metabolic regulation
MOTS-c is a mitochondria-derived peptide known for its role in regulating metabolic processes, boosting fat oxidation, and enhancing cellular energy output. Has been shown to increase insulin sensitivity, supporting more efficient glucose utilization. By promoting the use of stored fat as an energy source, may aid in reducing fat mass and optimizing body composition. Also helps protect cells from oxidative stress and supports recovery, contributing to improved stamina and vitality.
- Zheng Y, Wei Z, Wang T. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Front Endocrinol (Lausanne). 2023;14:1120533. PMID: 36761202 | DOI: 10.3389/fendo.2023.1120533
- Yin Y, et al. Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 Deubiquitination. Adv Sci (Weinh). 2024;11(43):e2405620. PMID: 39321430 | DOI: 10.1002/advs.202405620
- Yin Y, et al. The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitus. Pharmacol Res. 2022;175:105987. PMID: 34798268 | DOI: 10.1016/j.phrs.2021.105987
